Neuralink, the neurotechnology company founded by Elon Musk, has received FDA approval to implant its Telepathy brain chip in a second human participant. This follows the initial trial with Noland Arbaugh, a 30-year-old quadriplegic man who received the first implant in January. Arbaugh has reported significant improvements in his ability to control a computer and phone through thought alone, describing the technology as life-changing. Despite some technical issues with the first implant, such as the retraction of wires, Neuralink has proposed fixes, including embedding wires deeper into the brain. The company aims to implant up to ten people with the device this year, with the goal of advancing treatments for neurological disorders and improving the quality of life for patients with severe disabilities.